Fig 1: Comparison of serum Nrg4 and Nrg1 between GDM (n = 36) and normal controls (n = 38). (a) and (b) show the comparison of serum Nrg4 or Nrg1 in GDM and normal controls. (c) and (d) show the comparison of serum Nrg4 or Nrg1 according to BMI. Mann–Whitney U test was performed for all the comparison.
Fig 2: The predictive value of serum Nrg4, Nrg1, and their combination with inflammatory factors in GDM. (a) Nrg4, Nrg1 alone, and their combination for GDM diagnosis. (b) Nrg4 combined with inflammatory factors for GDM diagnosis. (c) Nrg1 combined with inflammatory factors for GDM diagnosis.
Fig 3: The prevalence of GDM in different Nrg4 or Nrg1 concentration ranges. (a) With the increases of Nrg4, the prevalence of GDM decreases gradually. (b) With the increases of Nrg1, the risk of GDM increases gradually. Trend χ2 test was used to assess the correlation between Nrg4 or Nrg1 levels and the prevalence of GDM.
Supplier Page from CUSABIO Technology LLC for Human neuregulin-4 (NRG4) ELISA Kit